Lexaria Awards CRO Contract for Upcoming U.S. Phase 1b Hypertension Study
Clinical study will evaluate safety and tolerability of Lexaria's patented DehydraTECH-CBD as a potential treatment for hypertensionCalifornia-based InClin to provide CRO services to manage and...
AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human...
Aqualung Therapeutics Concludes ALT-100 Antibody (mAb) Dosing in Its P1a Study with no Reported SAE’s. Will Engage FDA for Clearance of the P2a PUERTA Study in Moderate/Severe Acute Respiratory Distress Syndrome (ARDS) Patients
Aqualung has selected Novotech as their CRO partner to conduct the P2a PUERTA study in moderate/severe ARDS subjects.Expected screening for enrolled subjects to begin April/May...
Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications
Criterium, Inc., a full-service Contract Research Organization (CRO), is pleased to announce AURIC (Academic Urology Research Investigators Consortium) — a newly formed GU Oncology Consortium. The...
Only 35% of Tech CROs and Executives Are Very Satisfied With Partner Performance
New MarketBridge report reveals CROs' struggles and priorities in XaaS channel transformation amid an uncertain economy As technology businesses increasingly rely on channel partners to...
Proxima Clinical Research Named to Inc. Best in Business List
Proxima CRO among 241 companies recognized for putting purpose before profitHOUSTON, TX / ACCESSWIRE / January 18, 2023 / Proxima Clinical Research is proud to...